1 To whom correspondence should be addressed task (Mathur et al., 1996) . It is increasingly recognized that The aim of this study was to examine the role of serum and traditional determinants [e.g. serum oestradiol concentration follicular fluid pro-inflammatory cytokines and vascular on the day of human chorionic gonadotrophin (HCG) endothelial growth factor (VEGF) in the prediction of administration and the number of oocytes retrieved] do not ovarian hyperstimulation syndrome (OHSS). A total adequately define the risks for this syndrome and do not of 156 consecutive women undergoing in-vitro fertilizaaccurately predict its occurrence (Morris et al., 1995;  Chen tion were recruited. The study group comprised 12 women et al., 1997) . The potential value of cytokine measurements who subsequently developed moderate (n ⍧ 7) or severe (local and systemic) as complements to hormone tests in the (n ⍧ 5) OHSS. The two control groups were comprised of prediction of OHSS has not been fully investigated. Ideally, a randomized selection of 12 high-risk and 12 low-risk this prediction is best made prior to the administration of the women in whom OHSS did not develop. Serum was colovulatory HCG trigger, allowing cancellation of truly highlected on days of human chorionic gonadotrophin, oocyte risk treatment cycles. Previous work (Loret de Mola et al., retrieval, and embryo transfer. Serum and follicular fluid 1996; Lee et al., 1997) has shown that pre-ovulatory serum concentrations of interleukin (IL)-6, IL-8, tumour necrosis concentrations of IL-6, IL-1 receptor antagonist, TNF-α, and factor-α (TNF-α), and VEGF were measured. Follicular VEGF cannot predict the occurrence of OHSS. fluid IL-6 concentrations at the time of oocyte retrieval Because the onset of early-form OHSS (moderate or and serum IL-8 concentrations at the time of embryo severe) always presents several days after HCG administration transfer were significantly higher in the OHSS compared (Lyons et al., 1994) , if changes of these mediators occurred to the two control groups (P ⍧ 0.026 and P ⍧ 0.017 between the days of HCG administration (pre-ovulatory) and respectively). Serum concentrations of TNF-α and VEGF embryo transfer, these may be used to predict more specifically showed no statistically significant difference between the which patients will develop this complication. OHSS group and the controls at any studied time point.
The present study was undertaken to examine the possible This study suggests that follicular fluid IL-6 concentrations role of serum and follicular fluid concentrations of proat the time of oocyte retrieval and serum IL-8 concentrainflammatory cytokines (IL-6, IL-8, TNF-α) and VEGF as tions on the day of embryo transfer may serve as early predictors of OHSS. Simultaneous assessment made it possible predictors for this syndrome.Introduction
Ovarian hyperstimulation syndrome (OHSS) is a relatively common complication of ovarian stimulation and can be life Materials and methods threatening. The underlying mechanism responsible for the Subjects and study design clinical manifestations of OHSS appears to be an increase in From September 1998 to March 1999 capillary permeability of the mesothelial surface with acute fertilization (IVF) patients were recruited. All patients were followed fluid shift out of the intravascular space (Polishuk and for the development of OHSS. According to the classification Schenker, 1969) . Several recent reports suggest a pathoproposed by Golan et al. (1989) , seven (4.5%) had moderate OHSS physiological increase in follicular fluid, ascitic fluid, and and five (3.2%) had severe OHSS.
even serum concentrations of vasoactive mediators including
The study group was comprised of 12 patients who developed interleukin (IL)-6, IL-8, tumour necrosis factor-α (TNF-α) early-form moderate (n ϭ 7) or severe (n ϭ 5) OHSS requiring hospitalization. The two control groups were comprised of a (Friedlander et al., 1993; Abramov et al., 1996; Revel et al., randomized selection of 12 high-risk women and 12 low-risk was used if only two groups were being compared; the KruskalWallis one-way analysis of variance was used if more than two women in whom OHSS did not develop.
To define patients at high risk for the development of OHSS, the groups were being compared. For normally distributed data, analysis of variance was used. Spearman rank correlation was used to determine records of the women in the study group who subsequently developed moderate/severe OHSS were reviewed. Because it was revealed that if there were correlations between variables. Results are expressed as means Ϯ SD and means with 95% confidence intervals as the lowest serum oestradiol concentration on the day of HCG administration in these cases was 1665 pg/ml (conversion factor to appropriate. Statistical significance was defined as a value of P Ͻ 0.05. SI units, 3.671), this concentration was chosen as the threshold value for selection of control patients. Serum oestradiol concentration was
Results
chosen to define high-risk patients because this is the most commonly accepted risk factor for the development of OHSS (Delvigne et al., The clinical and laboratory data of patients in the study and 1993).
the two control groups are presented in Table I . There were no significant differences in any studied parameter between
Ovarian stimulation protocols the study group and the high-risk control group. However, The ovarian stimulation protocols were performed as previously significant differences were observed between the OHSS group described (Chen et al., 1999) . Briefly, pituitary desensitization was and the low-risk group in number of patients with polycystic initiated using buserelin (Supremon ® ; Hoechst, Frankfurt, Germany) ovary syndrome, serum oestradiol concentrations on the day by a long protocol, which was administered by intranasal spray from of HCG administration, number of oocytes retrieved, and the mid-luteal phase of the previous cycle at a dose of 200 µg, four number of embryos transferred (P Ͻ 0.05 for all variables).
times a day, until the day of menses. In the short protocol, buserelin Follicular fluid concentrations of IL-6 as well as progesterone was started on the second day of the treatment cycle and continued (Table II) were significantly higher in the OHSS group than at a dose of 200 µg, given four times a day until the day before transvaginal aspiration of oocytes. Follicle stimulating hormone (FSH, in the two control groups (P ϭ 0.026 and P ϭ 0.043 Metrodin ® ; Serono, Rome, Italy) (150 IU/day) and human menopausal respectively). Follicular fluid concentrations of IL-8, TNFgonadotrophin (HMG, Pergonal ® ; Serono) (150 IU/day) were injected α, VEGF, and oestradiol showed no statistically significant from cycle days 3-6 in the long protocol, while FSH and HMG were difference among the three groups. administered on cycle days 5 and 6 in the short protocol. Individualized Table III shows changes in the serum concentrations of injections of HMG were then continued until the administration of various cytokines and steroids on the days of HCG administra-HCG (10 000 IU, Profasi ® ; Serono) when two or more leading tion, oocyte retrieval, and embryo transfer. Serum IL-6 follicles had reached a diameter of 18 mm. Transvaginal oocyte concentrations on the day of HCG administration were retrieval was performed 34-36 h later. significantly higher in patients at risk for OHSS (OHSS and In all patients, peripheral venous blood was drawn in the high-risk control groups) than that in the low-risk control morning on the days of HCG administration, oocyte retrieval, and group (P ϭ 0.015, Mann-Whitney U test); however, no embryo transfer. Transvaginal oocyte retrieval was performed 34-36 h after HCG administration. All embryo transfers were performed 2 significant difference was observed between the OHSS group days after oocyte retrieval. During oocyte retrieval, clear follicular and the high-risk control group. Significantly elevated concenfluid from individual follicles of ജ18 mm was collected and pooled trations of IL-8 on the day of embryo transfer were observed in each patient. The follicular fluid was centrifuged immediately in the OHSS group compared to that in the two control groups (1000 g), and the supernatant was stored, together with the serum (P ϭ 0.017, Kruskal-Wallis test). Levels of TNF-α and VEGF samples, at -70°C before assay for cytokines and steroids.
showed no statistically significant difference between the OHSS group and the two control groups at any studied time Table IV shows the correlation coefficients of cytokine Los Angeles, CA, USA). The sensitivity of these cytokine assays concentrations with steroid concentrations in serum and was 1 pg/ml for IL-6, 2 pg/ml for IL-8, and 1.7 pg/ml for TNF-α. Serum and follicular VEGF concentrations were quantified using an progesterone at a concentration of 7.2 ng/ml.
Statistical analysis

Discussion
Statistical calculations were done using the Statistical Package for
The unique feature of this study is that multiple relevant the Social Sciences (version 9.0, SPSS Inc., Chicago, IL, USA). For data that were not normally distributed, the Mann-Whitney U test cytokines were assessed in serum and follicular fluid simultaneously in patients who subsequently developed OHSS tion that increased follicular fluid IL-6 concentrations at the time of oocyte retrieval may indicate the early stages of OHSS and controls who did not. The possible role of serial measurement of these mediators was also examined from the day of in IVF patients. The study further expanded on the assay of circulating IL-6 concentration by showing that serum IL-6 HCG administration up to the day of embryo transfer in the prediction of OHSS. It was found that follicular fluid IL-6 concentrations differed significantly on the days of HCG administration in the OHSS group compared to the low risk concentrations at the time of oocyte retrieval and serum IL-8 concentrations on the day of embryo transfer may serve as group. There was no difference between the OHSS and highrisk group without OHSS. Serum concentrations of IL-6 were early predictors for this syndrome.
A previous study has shown that IL-6 ribonucleic acid is also correlated to oestradiol concentrations. It is of note that the statistical results for serum IL-6 concentrations on the produced during follicular neovascularization (Motro et al., 1990) . The potential role of IL-6 in ovulation could be to days of HCG administration were on the lower detection concentrations for the assay and probably not clinically signienhance vascular permeability. Elevated concentrations of IL-6 in ascites and serum of women with OHSS were found ficant. This suggests the ovary may be the main resource of mediators that work as the initiators of the changes and lead (Friedlander et al.,1993) , suggesting its role as a marker of OHSS. In addition, it was found that elevated concentrations to the full appearance of OHSS. The findings of this study agree with previous studies of IL-6 in the follicular fluid at the time of oocyte retrieval may predict the development of early-form OHSS in high (Krasnow et al., 1996; Geva et al., 1999) , where no difference in follicular fluid VEGF concentrations was detected between responders (oestradiol concentrations Ͼ3000 pg/ml and/or 20 oocytes recovered) (Geva et al., 1997) . However, no compar-OHSS and controls. However, lower concentrations of VEGF were found in the follicular fluid of patients who were at risk ison was made with normal responders in whom OHSS did develop. The results of the current study confirm the observafor OHSS (Pellicer et al., 1999) . This finding is difficult to understand because excessive ovarian angiogenesis is a key OHSS compared with those who were not at risk. Agrawal et al. (1999) reported that the increase in the VEGF concentration that factor involved in the syndrome. The authors speculated that the ovary might not be involved initially in the pathogenesis occurred between the day of HCG administration and the day of oocyte retrieval (the 'VEGF rise') was an important nonof OHSS. Rather, a systemic response to HCG seems plausible. Whether these opposite patterns of VEGF found in follicular steroidal marker of OHSS. The VEGF rise predicted 40.3% of cases of moderate and severe OHSS, with no false-negative fluid are representative of regulation of the cytokine by other cytokines or steroid hormones requires further study.
results. However, the serum VEGF concentrations as a single marker during the early follicular phase, on the days of HCG Although some studies (Abramov et al., 1997; Artini et al., 1998; Pellicer et al., 1999; Agrawal et al., 1999) have administration, oocyte retrieval and embryo transfer did not predict the development of OHSS. Ludwig et al. (1999) established correlations between the development of OHSS and detectable circulating VEGF concentrations, the correlation described a correlation between the values of free VEGF on the day of HCG and the occurrence of OHSS, but could not is somewhat inconsistent. Pellicer et al. (1999) showed that there was a significant increase in serum VEGF concentrations show this effect for the total VEGF. The divergent results may be explained by different patient groups with inclusion of even after HCG administration in patients who were at risk for lower degree of OHSS and the small sample sizes in these This study had limitations. The present study design did not answer the question of whether serum IL-6 and IL-8 are studies. Another factor may be the kit used to measure VEGF independent risk factors, or just an epiphenomenona of high concentration in serum or plasma (Ludwig et al., 1999) . oestradiol values. A more reasonable study design would have Moreover, Lee et al. (1997) recently reported that serum been to obtain another control group without OHSS including VEGF concentrations at the time of oocyte retrieval are not patients who are matched to the group of patients with OHSS useful in predicting which patients undergoing IVF are at according to both age at oocyte retrieval and oestradiol values increased risk for the development of OHSS. Furthermore, on day of HCG administration. Furthermore, we have no Krasnow et al. (1996) did not find any significant difference prospective experience with measurements of serum and follicin pre-ovulatory and on day 7 after the ovulatory dose of ular fluid, pro-inflammatory cytokines and VEGF in a different HCG plasma VEGF concentrations between women who series of patients. Therefore, a prospective study is necessary subsequently developed OHSS and matched controls who did to evaluate the proposed predictors of OHSS. not. Thus, based on the work presented here and previous reports (Krasnow et al., 1996; Lee et al., 1997; Ludwig et al., 1998) , circulating VEGF concentrations from the day of HCG
